These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11365124)

  • 1. Hydroxyurea may enhance effectiveness of anti-HIV regimens presently in use.
    Murphy MJ
    Fac Notes (New Orleans La); 1998; 10(2):1-2. PubMed ID: 11365124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New data intensifies interest in hydroxyurea.
    Santiago LG
    GMHC Treat Issues; 1995 Sep; 9(9):1, 3-4. PubMed ID: 11362902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for the use of hydroxyurea as an anti-human immunodeficiency virus drug.
    Lori F; Lisziewicz J
    Clin Infect Dis; 2000 Jun; 30 Suppl 2():S193-7. PubMed ID: 10860905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyurea for HIV infection.
    Zachary KC; Davis B
    AIDS Clin Care; 1998 Apr; 10(4):25-6, 32. PubMed ID: 11365149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea: what it is. New Mexico AIDS InfoNet.
    Newsline People AIDS Coalit N Y; 1998 Mar; ():15. PubMed ID: 11367449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyurea for HIV?
    Treat Rev; 1998; (No 28):10-2. PubMed ID: 11365419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination treatment -- study results.
    Treat Rev; 1996 Dec; (No 23):4-11. PubMed ID: 11364282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of hydroxyurea in treatment of disease due to human immunodeficiency virus infection.
    Zala C; Rouleau D; Montaner JS
    Clin Infect Dis; 2000 Jun; 30 Suppl 2():S143-50. PubMed ID: 10860899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea in HIV therapy.
    HIV Hotline; 1998 Mar; 8(1):5-7. PubMed ID: 11365359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use of hydroxyurea in HIV-1 infected patients.
    Frank I
    J Biol Regul Homeost Agents; 1999; 13(3):186-91. PubMed ID: 10560754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update from the 5th Conference on Retroviruses and Opportunistic Infections.
    Vazquez E
    Posit Aware; 1998; 9(3):21-3. PubMed ID: 11365483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyurea.
    Gortner C
    BETA; 1998 Oct; ():7. PubMed ID: 11365996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyurea, a potential new anti-HIV agent.
    Torres G
    GMHC Treat Issues; 1995 Jan; 9(1):7-9. PubMed ID: 11367381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Hydroxyurea for real?
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1998 Aug; 4(8):6-16, 18. PubMed ID: 11365731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV treatment options.
    Smith D
    AIDS Treat News; 1998 May; (No 294):4-5. PubMed ID: 11365404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy in the management of HIV infection.
    Vella S; Franca Pirillo M
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl C():23-6. PubMed ID: 9003571
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyurea: overview of clinical data and antiretroviral and immunomodulatory effects.
    Lori F; Lisziewicz J
    Antivir Ther; 1999; 4 Suppl 3():101-8. PubMed ID: 16021881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug watch.
    Whitson S
    Posit Aware; 1999; 10(4):18-9. PubMed ID: 11366796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.